ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis.

Loss-of-function mutations in SWI/SNF chromatin-remodeling subunit genes are observed in many cancers, but an oncogenic role for SWI/SNF is not well established. Here, we reveal that ACTL6A, encoding an SWI/SNF subunit linked to stem cell and progenitor cell function, is frequently co-amplified and highly expressed together with the p53 family member p63 in head and neck squamous cell carcinoma (HNSCC). ACTL6A and p63 physically interact, cooperatively controlling a transcriptional program that promotes proliferation and suppresses differentiation, in part through activation of the Hippo-YAP pathway via regulators including WWC1. Ectopic ACTL6A/p63 expression promotes tumorigenesis, while ACTL6A expression and YAP activation are highly correlated in primary HNSCC and predict poor patient survival. Thus, ACTL6A and p63 collaborate as oncogenic drivers in HNSCC.

[1]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[2]  J. Pietenpol,et al.  The ΔNp63α Phosphoprotein Binds the p21 and 14-3-3σ Promoters In Vivo and Has Transcriptional Repressor Activity That Is Reduced by Hay-Wells Syndrome-Derived Mutations , 2003, Molecular and Cellular Biology.

[3]  M. Shannon,et al.  Chromatin Remodeling, Measured by a Novel Real-Time Polymerase Chain Reaction Assay, Across the Proximal Promoter Region of the IL-2 Gene , 2001, The Journal of Immunology.

[4]  B. Han,et al.  Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling. , 2015, Cancer research.

[5]  B. Teh,et al.  A novel panel of biomarkers predicts radioresistance in patients with squamous cell carcinoma of the head and neck. , 2014, European journal of cancer.

[6]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.

[7]  Angela N. Brooks,et al.  SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas. , 2014, The Journal of clinical investigation.

[8]  J. Hung,et al.  Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression , 2014, Oncogene.

[9]  Timothy R. Fallon,et al.  Yap tunes airway epithelial size and architecture by regulating the identity, maintenance, and self-renewal of stem cells. , 2014, Developmental cell.

[10]  A. McKenna,et al.  The Mutational Landscape of Head and Neck Squamous Cell Carcinoma , 2011, Science.

[11]  S. Xiao,et al.  Yes-Associated Protein Contributes to the Development of Human Cutaneous Squamous Cell Carcinoma via Activation of RAS. , 2016, The Journal of investigative dermatology.

[12]  C. Roberts,et al.  The SWI/SNF tumor suppressor complex , 2013, Nucleus.

[13]  Christopher P. Crum,et al.  p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development , 1999, Nature.

[14]  R. Gibbs,et al.  Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 , 2011, Science.

[15]  Eran Segal,et al.  Module map of stem cell genes guides creation of epithelial cancer stem cells. , 2008, Cell stem cell.

[16]  A. Dhar,et al.  The CCN family proteins in carcinogenesis. , 2010, Experimental oncology.

[17]  Jian-Hua Fu,et al.  The Impact of Tumor Cell Differentiation on Survival of Patients with Resectable Esophageal Squamous Cell Carcinomas , 2014, Annals of Surgical Oncology.

[18]  G. Crabtree,et al.  Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy , 2013, Nature Genetics.

[19]  A. Regev,et al.  An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors , 2008, Nature Genetics.

[20]  L. Ellisen,et al.  FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinoma. , 2013, The Journal of clinical investigation.

[21]  A. Hergovich,et al.  The Hippo pathway in disease and therapy: cancer and beyond , 2014, Clinical and Translational Medicine.

[22]  S. Gabriel,et al.  Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.

[23]  D. Wennmann,et al.  KIBRA: In the brain and beyond. , 2014, Cellular signalling.

[24]  J. Pietenpol,et al.  The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. , 2003, Molecular and cellular biology.

[25]  K. Guan,et al.  Disease implications of the Hippo/YAP pathway. , 2015, Trends in molecular medicine.

[26]  Howard Y. Chang,et al.  A novel ATAC-seq approach reveals lineage-specific reinforcement of the open chromatin landscape via cooperation between BAF and p63 , 2015, Genome Biology.

[27]  S. Bicciato,et al.  The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells , 2011, Cell.

[28]  G. Crabtree,et al.  ACTL6a enforces the epidermal progenitor state by suppressing SWI/SNF-dependent induction of KLF4. , 2013, Cell stem cell.

[29]  Keji Zhao,et al.  An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network , 2009, Proceedings of the National Academy of Sciences.

[30]  G. Crabtree,et al.  MicroRNA-mediated switching of chromatin-remodelling complexes in neural development , 2009, Nature.

[31]  L. Ellisen,et al.  ΔNp63α represses anti-proliferative genes via H2A.Z deposition. , 2012, Genes & development.

[32]  M. Koster.  p63 in skin development and ectodermal dysplasias. , 2010, The Journal of investigative dermatology.

[33]  Avi Ma'ayan,et al.  Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.

[34]  M. Brown,et al.  YAP Dysregulation by Phosphorylation or ΔNp63-mediated Gene Repression Promotes Proliferation, Survival and Migration in Head and Neck Cancer Subsets , 2010, Oncogene.

[35]  A. Ashworth,et al.  Genome-wide characterization reveals complex interplay between TP53 and TP63 in response to genotoxic stress , 2014, Nucleic acids research.

[36]  S. Sinha,et al.  ΔNp63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation , 2012, Development.

[37]  G. Crabtree,et al.  The BAF53a subunit of SWI/SNF-like BAF complexes is essential for hemopoietic stem cell function. , 2012, Blood.

[38]  Xaralabos Varelas,et al.  The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease , 2014, Development.

[39]  S. Jay,et al.  Dysregulated ΔNp63α Inhibits Expression of Ink4a/arf, Blocks Senescence, and Promotes Malignant Conversion of Keratinocytes , 2011, PloS one.

[40]  C. Van Waes,et al.  ΔNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation. , 2011, Cancer research.

[41]  Stefano Monti,et al.  A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma , 2015, Molecular Cancer Research.

[42]  H. Vogel,et al.  ΔNp63α is an oncogene that targets chromatin remodeler Lsh to drive skin stem cell proliferation and tumorigenesis. , 2011, Cell stem cell.

[43]  R. Moll,et al.  The human keratins: biology and pathology , 2008, Histochemistry and Cell Biology.

[44]  R. Gibbs,et al.  Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. , 2013, Cancer discovery.

[45]  F. McKeon,et al.  p63 Is Essential for the Proliferative Potential of Stem Cells in Stratified Epithelia , 2007, Cell.

[46]  C. Vakoc,et al.  A rationale to target the SWI/SNF complex for cancer therapy. , 2014, Trends in genetics : TIG.

[47]  S. Lowe,et al.  p63 deficiency activates a program of cellular senescence and leads to accelerated aging. , 2005, Genes & development.

[48]  M. Walsh,et al.  The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma. , 2014, Cancer cell.

[49]  A. Chatterjee,et al.  U-box-type ubiquitin E4 ligase, UFD2a attenuates cisplatin mediated degradation of ΔNp63α , 2008 .

[50]  Ruud H. Brakenhoff,et al.  The molecular biology of head and neck cancer , 2011, Nature Reviews Cancer.

[51]  G. Crabtree,et al.  Reversible Disruption of mSWI/SNF (BAF) Complexes by the SS18-SSX Oncogenic Fusion in Synovial Sarcoma , 2013, Cell.

[52]  D. Placantonakis,et al.  Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells , 2015, Nature Communications.

[53]  U. Moll,et al.  p63 and p73: roles in development and tumor formation. , 2004, Molecular cancer research : MCR.

[54]  Jun Li,et al.  TCPA: a resource for cancer functional proteomics data , 2013, Nature Methods.

[55]  G. Crabtree,et al.  Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics , 2015, Science Advances.

[56]  Thomas L. Dunwell,et al.  Frequent epigenetic inactivation of KIBRA, an upstream member of the Salvador/Warts/Hippo (SWH) tumor suppressor network, is associated with specific genetic event in B-cell acute lymphocytic leukemia , 2011, Epigenetics.

[57]  M. Lenarz,et al.  Biology and immunology of cancer stem(-like) cells in head and neck cancer. , 2015, Critical reviews in oncology/hematology.

[58]  A. Chatterjee,et al.  U-box-type ubiquitin E4 ligase, UFD2a attenuates cisplatin mediated degradation of DeltaNp63alpha. , 2008, Cell cycle.

[59]  W. Deng,et al.  Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. , 2010, Developmental cell.

[60]  H. Vogel,et al.  p63 is a p53 homologue required for limb and epidermal morphogenesis , 1999, Nature.

[61]  Li Li,et al.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. , 2007, Genes & development.

[62]  L. Ellisen,et al.  Basal cell signaling by p63 controls luminal progenitor function and lactation via NRG1. , 2014, Developmental cell.

[63]  W. Westra,et al.  Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. , 2009, Annual review of pathology.

[64]  Clifford A. Meyer,et al.  Cistrome: an integrative platform for transcriptional regulation studies , 2011, Genome Biology.